Treatments after first progression in metastatic colorectal cancer. A literature review and evidence-based algorithm
Author:
Publisher
Elsevier BV
Subject
Radiology Nuclear Medicine and imaging,Oncology,General Medicine
Reference119 articles.
1. FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study;Cremolini;Lancet Oncol,2015
2. Mutational Analysis of Patients With Colorectal Cancer in CALGB/SWOG 80405 Identifies New Roles of Microsatellite Instability and Tumor Mutational Burden for Patient Outcome;Innocenti;J Clin Oncol,2019
3. First-line chemotherapy for mCRC—a review and evidence-based algorithm;Cremolini;Nat Rev Clin Oncol,2015
4. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer;Van Cutsem;Ann Oncol,2016
5. Treatment sequencing in metastatic colorectal cancer;Modest;Eur J Cancer,2019
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Colorectal cancer;The Lancet;2024-07
2. Mebendazole; from an anti-parasitic drug to a promising candidate for drug repurposing in colorectal cancer;Life Sciences;2022-06
3. Targeting the DNA Damage Response Pathway as a Novel Therapeutic Strategy in Colorectal Cancer;Cancers;2022-03-09
4. Bone Metastases from Gastric Cancer: What We Know and How to Deal with Them;Journal of Clinical Medicine;2021-04-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3